364 related articles for article (PubMed ID: 17304029)
1. Human teratogens and evidence-based teratogen risk counseling: the Motherisk approach.
Nava-Ocampo AA; Koren G
Clin Obstet Gynecol; 2007 Mar; 50(1):123-31. PubMed ID: 17304029
[TBL] [Abstract][Full Text] [Related]
2. Valproic acid in pregnancy: how much are we endangering the embryo and fetus?
Ornoy A
Reprod Toxicol; 2009 Jul; 28(1):1-10. PubMed ID: 19490988
[TBL] [Abstract][Full Text] [Related]
3. A review of the contribution of whole embryo culture to the determination of hazard and risk in teratogenicity testing.
Webster WS; Brown-Woodman PD; Ritchie HE
Int J Dev Biol; 1997 Apr; 41(2):329-35. PubMed ID: 9184342
[TBL] [Abstract][Full Text] [Related]
4. Teratogen risk counselling by internet: a prospective cohort study.
Han JY; Yang JH; Chung JH; Choi JS; Ahn HK; Ryu HM; Kim MY; Cho SI; Nava-Ocampo AA
J Obstet Gynaecol; 2005 Jul; 25(5):427-31. PubMed ID: 16183573
[TBL] [Abstract][Full Text] [Related]
5. Teratogen update: valproic acid.
Lammer EJ; Sever LE; Oakley GP
Teratology; 1987 Jun; 35(3):465-73. PubMed ID: 3114906
[TBL] [Abstract][Full Text] [Related]
6. Environmental causes of human congenital malformations: the pediatrician's role in dealing with these complex clinical problems caused by a multiplicity of environmental and genetic factors.
Brent RL
Pediatrics; 2004 Apr; 113(4 Suppl):957-68. PubMed ID: 15060188
[TBL] [Abstract][Full Text] [Related]
7. Big risks in small groups: The difference between epidemiology and counselling.
Friedman JM
Birth Defects Res A Clin Mol Teratol; 2009 Aug; 85(8):720-4. PubMed ID: 19572407
[TBL] [Abstract][Full Text] [Related]
8. [Theoretical and applied aspects of experimental teratology].
Dyban AP
Ontogenez; 1977; 8(6):582-98. PubMed ID: 414184
[TBL] [Abstract][Full Text] [Related]
9. Update on new developments in the study of human teratogens.
Shepard TH; Brent RL; Friedman JM; Jones KL; Miller RK; Moore CA; Polifka JE
Teratology; 2002 Apr; 65(4):153-61. PubMed ID: 11948561
[TBL] [Abstract][Full Text] [Related]
10. Counseling regarding pregnancy--related drug exposures by family physicians in Ontario.
Goodwin J; Rieder S; Rieder MJ; Matsui D
Can J Clin Pharmacol; 2007; 14(1):e58-69. PubMed ID: 17314415
[TBL] [Abstract][Full Text] [Related]
11. Drugs in pregnancy.
Koren G; Pastuszak A; Ito S
N Engl J Med; 1998 Apr; 338(16):1128-37. PubMed ID: 9545362
[No Abstract] [Full Text] [Related]
12. Human teratogens: update 2010.
Holmes LB
Birth Defects Res A Clin Mol Teratol; 2011 Jan; 91(1):1-7. PubMed ID: 21254353
[TBL] [Abstract][Full Text] [Related]
13. What is a human teratogen: clinical and epidemiological criteria.
Bertollini R; Pagano M; Mastroiacovo P
Ann Ist Super Sanita; 1993; 29(1):97-104. PubMed ID: 8129277
[TBL] [Abstract][Full Text] [Related]
14. A survey of pregnant women using isotretinoin.
Robertson J; Polifka JE; Avner M; Chambers C; Delevan G; Koren G; Lavigne SV; Martinez LP; Miller RK; Carey JC
Birth Defects Res A Clin Mol Teratol; 2005 Nov; 73(11):881-7. PubMed ID: 16228976
[TBL] [Abstract][Full Text] [Related]
15. Informing patients of the teratogenic potential of mood stabilizing drugs: a case note review of the practice of psychiatrists.
James L; Barnes TR; Lelliott P; Taylor D; Paton C
J Psychopharmacol; 2007 Nov; 21(8):815-9. PubMed ID: 17881432
[TBL] [Abstract][Full Text] [Related]
16. Teratogen-induced limb defects.
Holmes LB
Am J Med Genet; 2002 Oct; 112(3):297-303. PubMed ID: 12357474
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the effectiveness of a teratogen information service: a survey of patient and professional satisfaction.
Ludowese CJ; Marini T; Laxova R; Pauli RM
Teratology; 1993 Sep; 48(3):233-45. PubMed ID: 8248861
[TBL] [Abstract][Full Text] [Related]
18. [Genetic counseling in relation to drug intake in early pregnancy].
Gedschold J; Becker R; Falk M
Arztl Jugendkd; 1990; 81(5):318-20. PubMed ID: 2100906
[TBL] [Abstract][Full Text] [Related]
19. Risk of drug-induced congenital defects.
De Santis M; Straface G; Carducci B; Cavaliere AF; De Santis L; Lucchese A; Merola AM; Caruso A
Eur J Obstet Gynecol Reprod Biol; 2004 Nov; 117(1):10-9. PubMed ID: 15474237
[TBL] [Abstract][Full Text] [Related]
20. How physicians perceive and utilize information from a teratogen information service: the Motherisk Program.
Einarson A; Park A; Koren G
BMC Med Educ; 2004 Apr; 4():6. PubMed ID: 15066201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
